INHIBITION OF HIV-1 REPLICATION BY CYTOTOXIC LYMPHOCYTES

细胞毒性淋巴细胞抑制 HIV-1 复制

基本信息

  • 批准号:
    3145912
  • 负责人:
  • 金额:
    $ 16.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-01-01 至 1994-12-31
  • 项目状态:
    已结题

项目摘要

Despite the identification of HIV-1 as the causative agent of the acquired immune deficiency syndrome (AIDS), definition of a protective immune response against the virus has remained an elusive goal. A vigorous cytotoxic lymphocyte (CTL) response to HIV-1 has been detected in infected individuals, and in vitro data indicate that lymphocytes from infected individuals of the CD8 phenotype can inhibit virus replication in vitro. Functional studies suggest that these cells are typical CTL, yet the relevant target antigens recognized have not been identified. Our laboratory has recently established a technique for the isolation and long-term propogation of HIV-1-specific CTL clones, and have mapped the actual CTL epitopes recognized by these cells using synthetic viral peptides. The purpose of this proposal is to examine the ability of CTL clones of defined epitope specificity to inhibit the replication of HIV-1 in order to determine the functional activity of these cells in vitro. Specifically, we propose to (1) examaine the ability of CTL clones to inhibit replication of HIV-1 in lymphocytes (2) examine the ability of CTL clones to inhibit HIV-1 replication in monocytes (3) determine the mechanisms of the CTL-induced inhibition of virus replication (4) determine the role of antigenic variation in escape from CTL recognition. These studies should both provide insight into the immunopathogenesis of HIV-1 infection, and are directly relevant to potential HIV-1 immunization and immunotherapy strategies.
尽管HIV-1已被确定为艾滋病的病原体

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bruce D Walker其他文献

Immunopathogenesis and immunotherapy in AIDS virus infections
艾滋病病毒感染的免疫发病机制和免疫治疗
  • DOI:
    10.1038/nm0703-861
  • 发表时间:
    2003-07-01
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Norman L Letvin;Bruce D Walker
  • 通讯作者:
    Bruce D Walker
Targeting the Hedgehog pathway iD therapy-resistant BCR-ABL1 positive leukemia with ponatinib
使用 ponatinib 靶向 Hedgehog 通路 iD 治疗耐药的 BCR-ABL1 阳性白血病
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Philip Mwimanzi;Tristan J Markle,Eric Martin;Yoko Ogata;Xiaomei TKuang;Michiyo Tokunaga;MacdonaldMahiti;Florencia Pereyra;ToshiyukiMiura;Bruce D Walker;Zabrina L Brumme,Mark A Brockman and *Takamasa Ueno;Katagiri S
  • 通讯作者:
    Katagiri S
Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants
  • DOI:
    10.1186/1742-4690-5-s1-o27
  • 发表时间:
    2008-04-09
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Andrew Prendergast;Wendy Mphatswe;Gareth Tudor-Williams;Natasha Blanckenberg;Ayanda Cengimbo;Prakash Jeena;Mpho Rakgotho;Visva Pillay;Christina Thobakgale;Sharon Reddy;Zenele Mncube;Mary Vanderstok;Noel McCarthy;Krista Dong;Hoosen Coovadia;Lynn Morris;Bruce D Walker;Philip Goulder
  • 通讯作者:
    Philip Goulder
Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members
HIV 控制者及其家庭成员中 ccr5 转录下调
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    E. Gonzalo;Patrick B Rapuano;Uchenna T Ikediobi;Rebecca Leibowitz;S. Mehta;Ayse K Coskun;J Zachary Porterfield;Teagan D Lampkin;Vincent C. Marconi;D. Rimland;Bruce D Walker;S. Deeks;Richard E Sutton
  • 通讯作者:
    Richard E Sutton
Programming CMV for vaccine vector design
为疫苗载体设计编程 CMV
  • DOI:
    10.1038/nbt.2688
  • 发表时间:
    2013-09-10
  • 期刊:
  • 影响因子:
    41.700
  • 作者:
    Srinika Ranasinghe;Bruce D Walker
  • 通讯作者:
    Bruce D Walker

Bruce D Walker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bruce D Walker', 18)}}的其他基金

Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs
了解和逆转 T 细胞功能障碍以控制和消除持续的 HIV 病毒库
  • 批准号:
    10308059
  • 财政年份:
    2019
  • 资助金额:
    $ 16.9万
  • 项目类别:
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs
了解和逆转 T 细胞功能障碍以控制和消除持续的 HIV 病毒库
  • 批准号:
    10523539
  • 财政年份:
    2019
  • 资助金额:
    $ 16.9万
  • 项目类别:
Understanding and Reversing T Cell Dysfunction to Control and Eliminate Persistent HIV Reservoirs
了解和逆转 T 细胞功能障碍以控制和消除持续的 HIV 病毒库
  • 批准号:
    9893507
  • 财政年份:
    2019
  • 资助金额:
    $ 16.9万
  • 项目类别:
Pathogenesis of Clade C HIV Infection
C 分支 HIV 感染的发病机制
  • 批准号:
    8962223
  • 财政年份:
    2016
  • 资助金额:
    $ 16.9万
  • 项目类别:
Pathogenesis of Clade C HIV Infection
C 分支 HIV 感染的发病机制
  • 批准号:
    9267895
  • 财政年份:
    2016
  • 资助金额:
    $ 16.9万
  • 项目类别:
Pathogenesis of Clade C HIV Infection
C 分支 HIV 感染的发病机制
  • 批准号:
    9485826
  • 财政年份:
    2016
  • 资助金额:
    $ 16.9万
  • 项目类别:
PD-1 expression and HIV specific T cell dysfunction
PD-1 表达和 HIV 特异性 T 细胞功能障碍
  • 批准号:
    8318852
  • 财政年份:
    2011
  • 资助金额:
    $ 16.9万
  • 项目类别:
Harvard University Center for AIDS Research
哈佛大学艾滋病研究中心
  • 批准号:
    8112961
  • 财政年份:
    2010
  • 资助金额:
    $ 16.9万
  • 项目类别:
Administrative
行政的
  • 批准号:
    7685006
  • 财政年份:
    2009
  • 资助金额:
    $ 16.9万
  • 项目类别:
Adaptive immunity in acute HIV infection
急性艾滋病毒感染中的适应性免疫
  • 批准号:
    8574935
  • 财政年份:
    2008
  • 资助金额:
    $ 16.9万
  • 项目类别:

相似海外基金

ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145834
  • 财政年份:
    1990
  • 资助金额:
    $ 16.9万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145832
  • 财政年份:
    1990
  • 资助金额:
    $ 16.9万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145835
  • 财政年份:
    1990
  • 资助金额:
    $ 16.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了